In September 2017, Aagami completed a busy and fruitful BioPharm America (BPA) 2017 conference with over 50 meetings. Dinesh Jain, CEO Aagami attended...
Published : 01 Oct 2017
Read MoreHappy with previous assignments delivered by Aagami, its Netherlands HQ'd client has given Aagami a broader and long term assignment, for partnering i...
Published : 20 Sep 2017
Read MoreAagami team are happy to anounced that their Louisiana based Biotechnology client have given another assignment (3rd from them) to sup...
Published : 08 Aug 2017
Read MoreThis time, Aagami has a new client from South Korea. The recent trips to the country has been fruitful. Apart from this new assignment, more are in di...
Published : 02 Jun 2017
Read MoreAnother day, Another assignment for Aaagami. Client is a high growth US MedTech, advancing the next generation of affordable, portable, minimally inva...
Published : 15 May 2017
Read MoreAagami has received a new assignment from a new client for strategic advisory and partnership development.Client is a bio-targeted nanomedicines ...
Published : 06 May 2017
Read MoreAagami announces a new client win. Aagami has received a mandate for strategic advisory and cross border licensing partnering.The UK based clien...
Published : 15 Apr 2017
Read MoreIn keeping up with the annual tradition, Aagami is participating in JP Morgan Healthcare conference and BioTech Showcase this January 2017. Both ...
Published : 09 Nov 2016
Read MoreAagami has been appointed for BD support, by an independent global Contract Research Organization (CRO) offering comprehensive non clinical GLP r...
Published : 01 Nov 2016
Read MoreA UK based pharma company has appointed Aagami to look for strategic partnership relating to their branded generics laxative for treatment of chronic ...
Published : 01 Nov 2016
Read More